A Randomized Controlled Non-Inferiority Trial Evaluating Opioid-Free versus Opioid-Sparing Analgesia for Orbital Fracture Reconstruction Under General Anesthesia
Rui Zhang,Yongjian Mai,Huijing Ye,Xiufen Lian,Huasheng Yang,Yanling Zhu,Xiaoliang Gan
DOI: https://doi.org/10.2147/jpr.s491994
IF: 2.8319
2024-11-13
Journal of Pain Research
Abstract:Rui Zhang, 1, &ast Yongjian Mai, 1, &ast Huijing Ye, 2, &ast Xiufen Lian, 2 Huasheng Yang, 2 Yanling Zhu, 1 Xiaoliang Gan 1 1 Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, People's Republic of China; 2 Department of Orbital Diseases and Ocular Oncology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, 510060, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaoliang Gan; Yanling Zhu, Email ; Background and Objectives: Opioid-minimizing strategies are making their appearance in enhanced recovery after surgery. This study is aimed to explore the potential advantages of opioid-free analgesia (OFA) compared to opioid-sparing analgesia (OSA) in patients undergoing orbital fracture reconstruction. Methods: In this prospective, single-center, randomized controlled study, we randomly recruited 122 patients undergoing orbital fracture reconstruction under general anesthesia. Patients received total intravenous anesthesia with a flexible laryngeal mask airway, and multimodal analgesia with either OSA or OFA methods. The OSA group (n = 61) received low doses of fentanyl and nonsteroidal anti-inflammatory drugs (NSAIDs), and the OFA group (n = 61) received medial canthus peribulbar block (MCPB) combined with NSAIDs. The primary outcomes consisted of area-under-the-curve (AUC) of the numerical rating scale (NRS) pain score, and the incidence of postoperative nausea and vomiting (PONV) through the first 24h. Results: Compared to the OSA group, the OFA group demonstrated non-inferiority in postoperative analgesia through the first 24 postoperative hours (difference of the medians, − 6; 95% confidence interval [CI], − 12 to 6), but failed to meet the non-inferiority criterion in the incidence of PONV (difference ratio, 3%; 95% CI, − 7% to 14%). The Quality of Recovery-40 questionnaire (QoR-40) scores on postoperative day 1 was significantly higher in group OFA compared to group OSA (188 [178 to 196] vs 181 [169 to 191], respectively; P = 0.005). Conclusion: In orbital fracture reconstruction, both OFA and OSA strategies provide effective postoperative pain relief, but OFA using MCPB combined NSAIDs enhances the quality of early postoperative recovery. Registered: Chinese Clinical Trial Registry ChiCTR1900028088. Keywords: peribulbar block, opioid-free, opioid-sparing, analgesia, orbital fracture reconstruction Over the past decades, the field of orbital surgery has greatly evolved with the aim of restoring and improving the structural integrity and function of the orbit. Surgical trauma following orbital procedures, such as orbital fracture reconstruction, is a complex issue involving both the soft tissue and bony injuries. 1 Our previous research has revealed that 62.5% of these patients experience significant postoperative pain, even when non-opioid analgesics such as acetaminophen and and nonsteroidal anti-inflammatory drugs (NSAIDs) are used. 2 Given that the majority of orbital reconstructions are now performed under general anesthesia on an enhanced recovery after surgery pathway, it is imperative to establish an effective and safe analgesic strategy to manage postoperative pain and enhance quality of recovery. Opioids play a crucial role in holistic perioperative analgesia with proven efficacy, reliability, and titratability. 3,4 In a study by Charlson et al, postoperative opioids were prescribed at a four times higher rate in oculoplastic and orbital surgeries than for procedures of other ophthalmic subspecialties. 5 However, reliance on opioid analgesia has well-documented acute side effects such as nausea and vomiting, and a serious long-term potential of opioid dependence. 6,7 The present opioid abuse epidemic has also gained significant attention in ophthalmic association, who is actively seeking alternatives that address postoperative pain in an efficacious manner because opioid-related adverse events can impair short-term recovery and extent hospital stays. 8,9 Modern multimodal analgesia protocols emphasise lower perioperative opioid use to avoid opioid-related adverse events and are referred to as opioid-sparing analgesia (OSA).<sup -Abstract Truncated-
clinical neurology